KDR and neoplasm: This was confirmed by another study with quercetin, which targeted the VEGFR-2-mediated angiogenic pathway, inhibited the expression of the downstream regulator AKT, and suppressed tumor growth in acute myeloid leukemia and breast cancer (Balakrishnan et al., 2016; Shi et al., 2020).